Show simple item record

FieldValueLanguage
dc.contributor.authorCheng, Shaokoon
dc.contributor.authorKourmatzis, Agisilaos
dc.contributor.authorMekonnen, Taye
dc.contributor.authorGholizadeh, Hanieh
dc.contributor.authorRaco, Joel
dc.contributor.authorTang, Patricia
dc.contributor.authorChan, Hak-Kim
dc.date.accessioned2021-03-02T02:19:00Z
dc.date.available2021-03-02T02:19:00Z
dc.date.issued2019en_AU
dc.identifier.urihttps://hdl.handle.net/2123/24585
dc.description.abstractKnowledge that enables the accurate simulation of drug deposition in the human upper airway is necessary to develop robust platforms for efficient drug delivery by inhalation devices. The human upper airway is deformable during inhalation but how it could affect deposition of inhaled drugs is unknown. We aimed to determine whether pharyngeal deformation at the soft palate level will have any significant effects on throat deposition, in vitro lung dose and fine particle fraction. In this study, dry mannitol powders were delivered to the next-generation cascade impactor (NGI) through the United States Pharmacopeia (USP) throat, and a realistic upper airway cast (RUPAC) at flow rates of 20 40, 60 and 80 Lmin-1. Deformation of the upper airway at 25%, 50%, and 75% in the lateral and antero posterior directions were experimentally simulated in the RUPAC. Throat deposition (p = 0.04) is significantly affected when the upper airway deforms laterally but not antero-posteriorly.en_AU
dc.language.isoenen_AU
dc.publisherElsevieren_AU
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivatives 4.0en_AU
dc.titleDoes Upper Airway Deformation Affect Drug Deposition?en_AU
dc.typeArticleen_AU
dc.identifier.doihttps://doi.org/10.1016/j.ijpharm.2019.118773
dc.relation.arcDP190101237
usyd.facultyEngineering, AMMEen_AU
workflow.metadata.onlyNoen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.